Carcinoembryonic antigen (CEA) is a fetal glycoprotein with a described role in surveillance and the prognosis of colorectal cancer and potential implications in other neoplasms, such as ovarian, cervical, lung, and breast cancers [9]. Here, CEACAM5 is linked to breast carcinoma.